Efficacy of Calcium Silicate Pulp-capping; a Randomized Controlled Clinical Trial
Reversible Pulpitis
About this trial
This is an interventional treatment trial for Reversible Pulpitis focused on measuring Indirect pulp capping, reversible pulpitis, periapical radiolucency, periapical radiographs, cone beam computed tomography, calcium silicate cements, glass ionomer cements, caries
Eligibility Criteria
Inclusion Criteria:
- Patients either male or female over the age of 16 (who can consent for themselves) in good general health
- A minimum of one carious lesion (occlusal, proximal, or MOD)
- Positive pulp response to electric pulp test and thermal stimulation.
Exclusion Criteria:
- Patients with clinical symptoms of irreversible pulpitis who need root canal treatment
- The presence of fistulas or swelling
- Anterior teeth with aesthetic concerns
- External or internal root resorption
- Multiple teeth with carious lesions in the same quadrant,
- Mobile teeth or tenderness to percussion.
- Pregnant women, in view of requirements for radiographs.
- Patients younger than 16.
- Patients unable to give consent
Sites / Locations
- King's College Dental Institute at Guy's Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Active Comparator
Active Comparator
calcium silicate cement (Biodentine™)
Cone Beam computed tomography (CBCT)
Periapical radiographs
Glass ionomer cement ( Fuji IX™)
calcium silicate cement (Biodentine™) used for indirect pulp capping of teeth with deep carious lesions and inflammed pulps.
CBCT scans are taken to assess the efficacy of this method in detecting the presence of early peri-radicular lesions.
Periapical radiographs are taken as a control to detect the presence of early peri-radicular lesions.
Glass ionomer cement ( Fuji IX™) used for indirect pulp capping of teeth with deep carious lesions and inflammed pulps.